Serum miRNAs measurements and diagnostic radioiodine whole body scintigraphy can be useful diagnostic tool in early identifying of persistent disease in differentiated thyroid cancer (DTC) patients with uninformative Tg values

被引：0
|
作者：
Campenni, A. [1 ]
Aguennouz, M. [2 ]
Vento, A. [1 ]
Polito, F. [2 ]
Comis, A. D. [1 ]
Di Giorgio, R. M. [2 ]
Panasiti, F. [1 ]
Ruggeri, R. M. [3 ]
Baldari, S. [1 ]
机构：
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Nucl Med Unit, Messina, Italy
[2] Univ Messina, Dept Clin & Expt Med, Neurol Unit, Messina, Italy
[3] Univ Messina, Dept Clin & Expt Med, Unit Endocrinol, Messina, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-172
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 43 条
  • [31] Clinical and diagnostic correlations between 18FDG-PET/CT and thyreoglobulin (Tg) in Patients affected by differentiated thyroid cancer (DTC) with negative 131I total body scan.
    Bertagna, F.
    Savelli, G.
    Bosio, G.
    Pizzocaro, C.
    Rodella, C.
    Merli, G.
    Bettinsoli, G.
    Maira, G.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S267 - S267
  • [32] Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment
    Pacini, F
    Capezzone, M
    Elisei, R
    Ceccarelli, C
    Taddei, D
    Pinchera, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1499 - 1501
  • [33] An added benefit of sequential stimulated diagnostic radioiodine whole body scans (WBS) and 18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) scans in the management of higher-risk differentiated thyroid cancer (DTC)
    Stocker, Derek
    Bonavia, Grant
    Hinds, Sidney
    Burch, Henry
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [34] Timing of post 131I ablation diagnostic whole body scan in differentiated thyroid cancer patients Less than four months post ablation may be too early
    Winter, M.
    Winter, J.
    Heinzel, A.
    Behrendt, F. F.
    Krohn, T.
    Mottaghy, F. M.
    Verburg, F. A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (04): : 151 - 157
  • [35] Diagnostic 131-I Whole Body Scan in the Evaluation of Patients with Differentiated Thyroid Cancer and Serum Thyroglobulin Levels < 1 ng/mL: Seven Years of Clinical Experience.
    Lucena, I.
    Costa, L.
    Teixeira, J.
    Martins, R.
    Couto, J.
    Lopes, F.
    Duarte, H.
    Soares, O.
    Bastos, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S449 - S449
  • [36] Clinical outcomes of negative serum thyroglobulin but positive diagnostic I-131 whole-body scans in patients with well-differentiated thyroid cancer after first remnant ablation
    Hu, Shuang
    Kuang, Anren
    Ji, Ting
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [37] Stimulated high serum thyroglobulin with negative whole body imaging do not warrant an aggressive diagnostic and therapeutic approach in differentiated thyroid cancer patients: A follow-up of 5 years or till recurrence
    Gupta, Manoj
    Choudhury, Partha. S.
    Nag, Sudipta
    Gupta, Parul
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (03): : 207 - 214
  • [38] Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up
    Frank Berger
    Ulla Friedrich
    Peter Knesewitsch
    Klaus Hahn
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 451 - 458
  • [39] Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk profile and long-term follow-up
    Berger, Frank
    Friedrich, Ulla
    Knesewitsch, Peter
    Hahn, Klaus
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) : 451 - 458
  • [40] Recurrence Rate of Tumor and the Value of Diagnostic I-131 Whole Body Scintigraphy and Recombinant TSH in Low-Risk Well Differentiated Thyroid Cancer Patients Who Have Had I-131 Radioablation
    Argon, Murat
    Yararbas, Ulkem
    Kumanlioglu, Kamil
    Ozkilic, Hayal
    TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2012, 32 (06): : 1693 - 1701
12345